Mindy M. Cheng, Ph.D. - Publications
Affiliations: | 2012 | Pharmacy | University of Washington, Seattle, Seattle, WA |
Area:
Pharmacy, OncologyYear | Citation | Score | |||
---|---|---|---|---|---|
2021 | Hendrix N, Veenstra DL, Cheng M, Anderson NC, Verguet S. Assessing the Economic Value of Clinical Artificial Intelligence: Challenges and Opportunities. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 25: 331-339. PMID 35227443 DOI: 10.1016/j.jval.2021.08.015 | 0.415 | |||
2012 | Cheng MM, Ramsey SD, Devine EB, Garrison LP, Bresnahan BW, Veenstra DL. Systematic review of comparative effectiveness data for oncology orphan drugs. The American Journal of Managed Care. 18: 47-62. PMID 22435748 | 0.477 | |||
2012 | Cheng MM, Goulart B, Veenstra DL, Blough DK, Devine EB. A network meta-analysis of therapies for previously untreated chronic lymphocytic leukemia. Cancer Treatment Reviews. 38: 1004-11. PMID 22405931 DOI: 10.1016/J.Ctrv.2012.02.006 | 0.4 | |||
2010 | Cheng MM, Alfonso R, Best JH, Garrison LP, Bruhn D, Veenstra DL. The economic value of reducing medication dosing frequency with drug delivery technologies: an evidence assessment. Journal of Medical Economics. 13: 193-202. PMID 20334490 DOI: 10.3111/13696991003757500 | 0.54 | |||
2009 | Cheng MM, Lu B, Hu SS, Marelli C, Higashi MK, Patel PA, Li J, Veenstra DL. Optimizing CAD diagnosis in China with CT angiography. Journal of Cardiovascular Computed Tomography. 3: 153-8. PMID 19394919 DOI: 10.1016/J.Jcct.2009.03.005 | 0.485 | |||
Show low-probability matches. |